NCT00000804撤回不适用
A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)
适应症
相关药物
试验速览
研究概览
简要总结
The purpose of this trial is to study L-735,524, which is an inhibitor of the HIV protease enzyme. It will be used with interleukin-2 in patients infected with HIV.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
2 期
A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken IndinavirHIV InfectionsNCT00002452Merck Sharp & Dohme LLC30
暂停
2 期
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and LamivudineHIV InfectionsNCT00002424Merck Sharp & Dohme LLC186
已完成
2 期
Study to Evaluate a HIV Drug for the Treatment of HIV InfectionInfection, Human Immunodeficiency VirusHIV InfectionsNCT01803074ViiV Healthcare107
已完成
1 期
Safety Study of IL-7 in HIV-infected Patients (Inspire)HIV InfectionsLymphopeniaNCT00477321Cytheris SA30
已完成
1 期
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV PatientsHepatitis C, ChronicNCT00905632Boehringer Ingelheim75